Credit Suisse Ag Uro Gen Pharma Ltd. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Credit Suisse Ag holds 1,200,000 shares of URGN stock, worth $20.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,200,000

Previous 1,200,000 -0.0%

Holding current value

$20.1 Million

Previous $18 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$10.87 - $15.93 $1.52 Million - $2.23 Million	140,000 Added 13.21%	1,200,000 $18 Million
Q3 2022 Nov 10, 2022	SELL	$7.21 - $9.41 $72 - $94	-10 Reduced -0.0%	1,060,000 $8.82 Million
Q2 2022 Aug 12, 2022	SELL	$5.12 - $8.74 $130,616 - $222,966	-25,511 Reduced 2.35%	1,060,010 $8.68 Million
Q1 2022 May 16, 2022	SELL	$5.92 - $9.73 $1,349 - $2,218	-228 Reduced 0.02%	1,085,521 $9.46 Million
Q4 2021 Feb 14, 2022	BUY	$9.03 - $19.13 $704 - $1,492	78 Added 0.01%	1,085,749 $10.3 Million

Q3 2021 Nov 12, 2021	SELL	$14.31 - $18.39 $2,819 - $3,622	-197 Reduced 0.02%	1,085,671 $18.3 Million
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $529,613 - $729,612	-34,843 Reduced 3.11%	1,085,868 $16.6 Million
Q1 2021 May 14, 2021	SELL	$17.99 - $26.96 $6,476 - $9,705	-360 Reduced 0.03%	1,120,711 $21.8 Million
Q4 2020 Feb 12, 2021	BUY	$17.54 - $25.43 $119,061 - $172,618	6,788 Added 0.61%	1,121,071 $20.2 Million
Q3 2020 Nov 13, 2020	BUY	$18.81 - $26.42 $3.78 Million - $5.31 Million	201,105 Added 22.02%	1,114,283 $21.5 Million
Q2 2020 Aug 12, 2020	BUY	$16.5 - $29.7 $4.03 Million - $7.25 Million	244,175 Added 36.5%	913,178 $23.9 Million
Q1 2020 May 13, 2020	SELL	$13.68 - $34.6 $5,909 - $14,947	-432 Reduced 0.06%	669,003 $11.9 Million
Q4 2019 Feb 12, 2020	BUY	$21.11 - $34.86 $632,751 - $1.04 Million	29,974 Added 4.69%	669,435 $22.3 Million
Q3 2019 Nov 12, 2019	BUY	$23.83 - $36.44 $1.59 Million - $2.44 Million	66,899 Added 11.68%	639,461 $15.2 Million
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $1.87 Million - $2.3 Million	56,953 Added 11.05%	572,562 $20.6 Million
Q1 2019 May 14, 2019	BUY	$35.47 - $54.55 $2.8 Million - $4.31 Million	79,033 Added 18.1%	515,609 $19 Million
Q4 2018 Feb 13, 2019	BUY	$38.35 - $50.39 $642,285 - $843,931	16,748 Added 3.99%	436,576 $18.8 Million
Q3 2018 Nov 13, 2018	BUY	$41.65 - $51.7 $6.07 Million - $7.53 Million	145,627 Added 53.11%	419,828 $19.8 Million
Q2 2018 Aug 14, 2018	SELL	$48.35 - $65.33 $3.76 Million - $5.08 Million	-77,799 Reduced 22.1%	274,201 $13.6 Million
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $4.95 Million - $7.37 Million	128,000 Added 57.14%	352,000 $17.5 Million
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $3.38 Million - $5.36 Million	124,000 Added 124.0%	224,000 $8.34 Million
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $1.71 Million - $3.27 Million	100,000	100,000 $3.15 Million

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $382M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account